dr. tagawa on updated results of taxynergy trial in prostate cancer
Published 7 years ago • 103 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
1:32
dr. tagawa on next steps for taxanes in prostate cancer
-
2:29
dr. tagawa on brca2 in patients with prostate cancer receiving psma-targeted radionuclide therapy
-
1:40
dr. tagawa on targeting psma in prostate cancer
-
1:18
dr. tagawa discusses radiotherapy in prostate cancer
-
2:06
dr. tagawa on ctc in neuroendocrine-positive prostate cancer
-
1:11
scott tagawa, md, shares results of phase 1 dose escalation study of 225ac-j591 in mpc patients
-
2:04
dr. beer on the design and results of the prevail trial
-
2:31
dr. tagawa on abiraterone and docetaxel in mcrpc
-
5:28
psma imaging: vision trial with dr. scott tagawa
-
1:49
dr. tagawa on preliminary data with 225ac-j591 in mcrpc
-
1:18
dr. higano on the getug-afu 16 trial results in prostate cancer
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
6:41
esmo expert report on combination therapy in advanced prostate cancer @ asco gu 2022
-
7:17
scott tagawa, md, on psma targeting in prostate cancer treatment
-
1:14
dr. dreicer on abiraterone and enzalutamide in prostate cancer
-
0:44
dr. gomella on enzalutamide in prostate cancer
-
5:06
asco 2019: dr. tagawa highlights key prostate cancer data
-
1:23
dr. morris on safety profiles of ar inhibitors in prostate cancer
-
5:49
scott tagawa, md, on the impact of racial disparity and covid-19 on prostate cancer clinical trials